The Life Science Market will witness a CAGR of 4%, reaching US$ 4,200 Million between 2024. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.
According to a study conducted by Persistence Market Research (PMR) on the global market for life science products, incessant progress in the field of biotech science has led to the development of various new-age and consumer-friendly life science products in recent years. The PMR study reveals that the global life science products market is set to witness a CAGR of over 4% in terms of revenue between 2016 -2024. The market is expected to create an absolute $ opportunity of US$ 114.9 Million in 2017 over 2016.
Availability of advanced technological support and a continuously expanding information database owing to intensive analysis and combined research expeditions on various life science topics has resulted in the development of novel therapeutics. Accordingly, the arrival of latest antibody manufacturing methods has greatly improved the overall propositions of scientific research and analysis activities.
Planning Forward? Access Sample of Life Science Market Report! https://www.persistencemarketresearch.com/samples/9986
Company Profiles
- Abcam Plc
- M.S. Biotechnology (Europe) Limited
- Bio-Rad Laboratories Inc.
- BPS Bioscience Inc.
- Crown Bioscience Inc.
- Genscript Biotech Corporation
- Merck Millipore Limited
- PerkinElmer Inc.
- Sigma Aldrich Corp.
- Thermo Fisher Scientific Inc.
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Life Science Market? https://www.persistencemarketresearch.com/methodology/9986
Likewise, the emergence of academia as the primary organization for conducting basic research is expected to accelerate the growth of the life science products market.
Bottlenecks
PMR indicates that low reproducibility of research and poor specificity of products coupled with high cost of technology restricting robust adoption are the major impediments of the market. Further, lengthy lead durations for custom research requirements may also inhibit the overall market growth.
Market Overview
Based on product type, demand for antibodies is expected to remain high during the forecasted period. In 2015, the antibodies segment accounted for nearly 83% share of the market in terms value. This is primarily due to higher investment in R&D pipelines, especially in the region of Asia Pacific. The antibodies segment is followed by recombinant proteins segment, which is projected to surpass a market valuation of over US$ 470 Million by 2024-end.
On the basis of application, basic research is the predominant segment of the market estimated to reach a market valuation of US$ 2,600.5 million by the end of the assessment period. Whereas, the drug discovery and development segment is projected to witness the highest growth rate, reflecting a CAGR of 4.7% over the period of forecast.
Planning To Introduce An Offbeat Product/Technology In The Life Science Market? Go To “Purchase Now” To Have Our Life Science Market Report! https://www.persistencemarketresearch.com/checkout/9986
In addition, the current market valuation of drug discovery & development is US$ 350.5 Million, which is estimated to surpass US$ 506 Million by the end of 2024.
Based on end-user, academic and research institutes is the leading segment of the market. In 2015 the segment accounted for over 42% share of the market in 2015. In terms of growth, contract research organizations is anticipated to be the fastest growing segment, registering 5.3% CAGR over the assessment period.
Access Related Reports:
Polycystic Ovary Syndrome Drugs Market:
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024.
Cardiac Arrhythmia Monitoring Devices Market:
The analysis includes past data and statistics, the market scenario in 2017 as well as market forecast pertaining to value and volume projections for a period of eight years (2017-2025). Various aspects impacting the growth of the global cardiac arrhythmia monitoring devices market are also covered in the report.
Dental Biomaterials Market:
According to the latest research by the company, the global dental biomaterials market is expected to account for over US$ 1,880.0 Mn, in terms of value, by the end of 2026. The dental biomaterials market is expected to witness substantial growth at a CAGR of 4.4% through 2026.
Emergency Hospital Beds Market:
The emergency hospital beds market includes a variety of products such as surgical beds, bariatric beds, critical care beds, emergency and transport stretchers, speciality stretchers, and others. Key manufacturers also offer various products based on different technologies such as electric-powered or manual stretchers.
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com